Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
Company profile
Ticker
AORT
Exchange
Website
CEO
James Mackin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
Former names
CRYOLIFE INC
SEC CIK
Corporate docs
Subsidiaries
Ascyrus Medical GmbH • Ascyrus Medical LLC • AuraZyme Pharmaceuticals, Inc. • CryoLife Asia Pacific, PTE. Ltd • CryoLife Beijing Medical Device Ltd. • CryoLife Canada, Inc. • CryoLife Europa, Ltd. • CryoLife France, SAS. • CryoLife Germany HoldCo GmbH. • CryoLife Germany TopCo GmbH ...
IRS number
592417093
AORT stock data
Latest filings (excl ownership)
8-K
Changes in Control of Registrant
9 Nov 22
10-Q
2022 Q3
Quarterly report
4 Nov 22
8-K
Artivion Reports Third Quarter 2022 Financial Results
3 Nov 22
8-K
Elizabeth Hoff Joins Artivion Board of Directors
29 Sep 22
8-K
Regulation FD Disclosure
23 Sep 22
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
5 Aug 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
8-K
Artivion Reports Second Quarter 2022 Financial Results
4 Aug 22
SD
Conflict minerals disclosure
26 May 22
S-8
Registration of securities for employees
24 May 22
Transcripts
AORT
Earnings call transcript
2022 Q2
7 Aug 22
AORT
Earnings call transcript
2022 Q1
8 May 22
AORT
Earnings call transcript
2021 Q4
18 Feb 22
AORT
Earnings call transcript
2021 Q3
7 Nov 21
AORT
Earnings call transcript
2021 Q2
1 Aug 21
AORT
Earnings call transcript
2021 Q1
1 May 21
AORT
Earnings call transcript
2020 Q4
12 Feb 21
AORT
Earnings call transcript
2020 Q3
4 Nov 20
AORT
Earnings call transcript
2020 Q2
31 Jul 20
AORT
Earnings call transcript
2020 Q1
2 May 20
Latest ownership filings
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
6 Feb 23
5
Marshall S. Stanton
27 Jan 23
5
Jean F Holloway
27 Jan 23
5
Dennis B Maier
27 Jan 23
5
John E Davis
27 Jan 23
SC 13G/A
BlackRock Inc.
26 Jan 23
SC 13G
BlackRock Inc.
20 Jan 23
4
Amy Horton
16 Dec 22
4
Amy Horton
10 Nov 22
4
Franz Peter Barthold
10 Nov 22
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 37.57 mm | 37.57 mm | 37.57 mm | 37.57 mm | 37.57 mm | 37.57 mm |
| Cash burn (monthly) | 936.67 k | 2.30 mm | 4.18 mm | 2.21 mm | (no burn) | 351.67 k |
| Cash used (since last report) | 4.05 mm | 9.92 mm | 18.05 mm | 9.55 mm | n/a | 1.52 mm |
| Cash remaining | 33.52 mm | 27.65 mm | 19.52 mm | 28.03 mm | n/a | 36.05 mm |
| Runway (months of cash) | 35.8 | 12.0 | 4.7 | 12.7 | n/a | 102.5 |
Institutional ownership, Q3 2022
83.7% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 130 |
| Opened positions | 14 |
| Closed positions | 18 |
| Increased positions | 49 |
| Reduced positions | 42 |
| 13F shares | Current |
|---|---|
| Total value | 466.86 mm |
| Total shares | 33.74 mm |
| Total puts | 0.00 |
| Total calls | 40.40 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BLK Blackrock | 7.24 mm | $100.18 mm |
| Vanguard | 2.75 mm | $38.03 mm |
| MCQEF Macquarie | 2.59 mm | $35.91 mm |
| Wasatch Advisors | 2.13 mm | $29.50 mm |
| Juniper Investment | 2.09 mm | $28.94 mm |
| MS Morgan Stanley | 1.97 mm | $27.26 mm |
| Dimensional Fund Advisors | 1.44 mm | $19.97 mm |
| Wellington Management | 1.40 mm | $19.36 mm |
| GW&K Investment Management | 1.36 mm | $18.78 mm |
| Perceptive Advisors | 1.20 mm | $16.67 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Jan 23 | Davis John E | Common Stock | Grant | Acquire A | No | No | 16.048 | 1,228 | 19.71 k | 111,272 |
| 24 Jan 23 | Maier Dennis B | Common Stock | Grant | Acquire A | No | No | 16.048 | 211 | 3.39 k | 42,465 |
| 24 Jan 23 | Holloway Jean F | Common Stock | Grant | Acquire A | No | No | 10.302 | 384 | 3.96 k | 124,883 |
| 24 Jan 23 | Holloway Jean F | Common Stock | Grant | Acquire A | No | No | 16.048 | 866 | 13.90 k | 124,499 |
| 24 Jan 23 | Marshall S. Stanton | Common Stock | Grant | Acquire A | No | No | 10.302 | 443 | 4.56 k | 40,448 |
| 24 Jan 23 | Marshall S. Stanton | Common Stock | Grant | Acquire A | No | No | 16.048 | 810 | 13.00 k | 40,005 |
| 14 Dec 22 | Horton Amy | Common Stock | Gift | Dispose G | No | No | 13.21 | 2,000 | 26.42 k | 99,950 |
| 14 Dec 22 | Horton Amy | Common Stock | Sell | Dispose S | No | No | 13.5718 | 3,226 | 43.78 k | 101,950 |